BioSpace News Archive

On July 10th, Chengdu Hi-tech Zone and Gilead Sciences inked a strategic cooperation agreement on the Gilead Sciences Western China Operation Center project, which marked the official registration of its western China operation center in Chengdu Hi-tech Zone.

NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a regenerative medicine company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases, today reports the publication of a new, independent study using NervGen’s core Intracellular Sigma Peptide (“ISP”) technology in a mouse model representative of demyelination in multiple sclerosis.

The results that Janssen presented at ASCO show that ADC-1013 can be administered in considerably higher doses than any of the other CD40 antibodies in clinical development.

Healx, the Cambridge technology company developing breakthrough treatments for rare diseases, announces the appointment of Dr Neil Thompson, PhD, as Chief Scientific Officer.

H2-Pharma, LLC, a privately held pharmaceutical company, announced that it has entered into an agreement with CHEPLAPHARM Arzneimittel GmbH to be the exclusive U.S. distributor of ETOPOPHOS® for injection.

The increasing prevalence of sleep disorders and breathing problems is boosting the demand for internal nasal dilators.

Indivior PLC announced revised expectations for FY 2019 net revenue and net income following stronger than expected H1 2019 net revenue performance.

Hall of Famer and four time Super Bowl champion continues to feel the physical effects of his playing career that ended in 1994.

Percutaneous nephrostomy procedures have gained immense popularity over the last few years as they eliminate the need for nephrostomy tube or ureteral stent devices.

Greene Tweed, a leading global manufacturer of high-performance seals, thermoplastics, composites, and engineered components, highlights its sealing solutions for pharmaceutical processing.